4.8 Article

BAX and BAK1 are dispensable for ABT-737-induced dissociation of the BCL2-BECN1 complex and autophagy

Journal

AUTOPHAGY
Volume 11, Issue 3, Pages 452-459

Publisher

TAYLOR & FRANCIS INC
DOI: 10.1080/15548627.2015.1017191

Keywords

ABT-737; apoptosis; autophagy; BAX; BAK1; BCL2; BECN1 (Beclin 1); ACTB; actin; Baf A1; bafilomycin A(1); BAK1; BCL2-antagonist; killer 1; BAX; BCL2-associated X protein; BCL2; B-cell CLL; lymphoma 2; BECN1; Beclin 1; autophagy-related; DKO; double-knockout; FBS; fetal bovine serum; GAPDH; glyceraldehyde-3-phosphate dehydrogenase; HBSS; Hanks' balanced salt solution; HRP; horseradish peroxidase; MAP1LC3; LC3; microtubule-associated protein 1 light chain 3; MCL1; myeloid cell leukemia 1; MEFs; mouse embryonic fibroblasts; MTOR; mechanistic target of rapamycin; PBS; phosphate-buffered saline; SQSTM1; sequestosome 1; STS; staurosporine; WT; wild type

Categories

Funding

  1. CPRIT [RP120718-P1]
  2. NIH [R01CA109618, U19AI109725]
  3. Ligue contre le Cancer
  4. Agence National de la Recherche (ANR)
  5. Association pour la recherche sur le cancer (ARC)
  6. Canceropole Ile-de-France
  7. Institut National du Cancer (INCa)
  8. Fondation Bettencourt-Schueller
  9. Fondation de France
  10. Fondation pour la Recherche Medicale (FRM)
  11. European Commission (ArtForce)
  12. European Research Council (ERC)
  13. LabEx Immuno-Oncology
  14. SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE)
  15. SIRIC Cancer Research and Personalized Medicine (CARPEM)
  16. Paris Alliance of Cancer Research Institutes (PACRI)

Ask authors/readers for more resources

Disruption of the complex of BECN1 with BCL2 or BCL2L1/BCL-X-L is an essential switch that turns on cellular autophagy in response to environmental stress or treatment with BH3 peptidomimetics. Recently, it has been proposed that BCL2 and BCL2L1/BCL-X-L may inhibit autophagy indirectly through a mechanism dependent on the proapoptotic BCL2 family members, BAX and BAK1. Here we report that the BH3 mimetic, ABT-737, induces autophagy in parallel with disruption of BCL2-BECN1 binding in 2 different apoptosis-deficient cell types lacking BAX and BAK1, namely in mouse embryonic fibroblasts cells and in human colon cancer HCT116 cells. We conclude that the BH3 mimetic ABT-737 induces autophagy through a BAX and BAK1-independent mechanism that likely involves disruption of BECN1 binding to antiapoptotic BCL2 family members.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available